253 related articles for article (PubMed ID: 8134338)
1. Sequence-specific transcriptional activation is essential for growth suppression by p53.
Pietenpol JA; Tokino T; Thiagalingam S; el-Deiry WS; Kinzler KW; Vogelstein B
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):1998-2002. PubMed ID: 8134338
[TBL] [Abstract][Full Text] [Related]
2. Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53.
Leiter LM; Chen J; Marathe T; Tanaka M; Dutta A
Oncogene; 1996 Jun; 12(12):2661-8. PubMed ID: 8700525
[TBL] [Abstract][Full Text] [Related]
3. The strength of acidic activation domains correlates with their affinity for both transcriptional and non-transcriptional proteins.
Melcher K
J Mol Biol; 2000 Sep; 301(5):1097-112. PubMed ID: 10966808
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation by DNA-binding derivatives of HSV-1 VP16 that lack the carboxyl-terminal acidic activation domain.
Popova B; Bilan P; Xiao P; Faught M; Capone JP
Virology; 1995 May; 209(1):19-28. PubMed ID: 7747469
[TBL] [Abstract][Full Text] [Related]
5. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
6. Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity.
Candau R; Scolnick DM; Darpino P; Ying CY; Halazonetis TD; Berger SL
Oncogene; 1997 Aug; 15(7):807-16. PubMed ID: 9266967
[TBL] [Abstract][Full Text] [Related]
7. Activation of chromosomal DNA replication in Saccharomyces cerevisiae by acidic transcriptional activation domains.
Li R; Yu DS; Tanaka M; Zheng L; Berger SL; Stillman B
Mol Cell Biol; 1998 Mar; 18(3):1296-302. PubMed ID: 9488444
[TBL] [Abstract][Full Text] [Related]
8. p53 amino acids 339-346 represent the minimal p53 repression domain.
Hong TM; Chen JJ; Peck K; Yang PC; Wu CW
J Biol Chem; 2001 Jan; 276(2):1510-5. PubMed ID: 11007800
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 Tat binding protein-1 is a transcriptional coactivator specific for TR.
Ishizuka T; Satoh T; Monden T; Shibusawa N; Hashida T; Yamada M; Mori M
Mol Endocrinol; 2001 Aug; 15(8):1329-43. PubMed ID: 11463857
[TBL] [Abstract][Full Text] [Related]
10. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
11. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
Agostini I; Navarro JM; Rey F; Bouhamdan M; Spire B; Vigne R; Sire J
J Mol Biol; 1996 Sep; 261(5):599-606. PubMed ID: 8800208
[TBL] [Abstract][Full Text] [Related]
12. In vivo requirement of activator-specific binding targets of mediator.
Park JM; Kim HS; Han SJ; Hwang MS; Lee YC; Kim YJ
Mol Cell Biol; 2000 Dec; 20(23):8709-19. PubMed ID: 11073972
[TBL] [Abstract][Full Text] [Related]
13. The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.
Lee TH; Moffett P; Pelletier J
Nucleic Acids Res; 1999 Jul; 27(14):2889-97. PubMed ID: 10390530
[TBL] [Abstract][Full Text] [Related]
14. GCN5 dependence of chromatin remodeling and transcriptional activation by the GAL4 and VP16 activation domains in budding yeast.
Stafford GA; Morse RH
Mol Cell Biol; 2001 Jul; 21(14):4568-78. PubMed ID: 11416135
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activators direct histone acetyltransferase complexes to nucleosomes.
Utley RT; Ikeda K; Grant PA; Côté J; Steger DJ; Eberharter A; John S; Workman JL
Nature; 1998 Jul; 394(6692):498-502. PubMed ID: 9697775
[TBL] [Abstract][Full Text] [Related]
16. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.
Shimada A; Kato S; Enjo K; Osada M; Ikawa Y; Kohno K; Obinata M; Kanamaru R; Ikawa S; Ishioka C
Cancer Res; 1999 Jun; 59(12):2781-6. PubMed ID: 10383130
[TBL] [Abstract][Full Text] [Related]
17. Useful vectors for the two-hybrid system in mammalian cells.
Buchert M; Schneider S; Adams MT; Hefti HP; Moelling K; Hovens CM
Biotechniques; 1997 Sep; 23(3):396-8, 400, 402. PubMed ID: 9298205
[No Abstract] [Full Text] [Related]
18. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
Wang L; Grossman SR; Kieff E
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):430-5. PubMed ID: 10618435
[TBL] [Abstract][Full Text] [Related]
19. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators.
Ito M; Yuan CX; Malik S; Gu W; Fondell JD; Yamamura S; Fu ZY; Zhang X; Qin J; Roeder RG
Mol Cell; 1999 Mar; 3(3):361-70. PubMed ID: 10198638
[TBL] [Abstract][Full Text] [Related]
20. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
Hansen RS; Braithwaite AW
Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
